V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10005407 | 10003370 | 1.68 | 52.2 | Adjuvant (A) | 2018-01-14 | 2018-01-24 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 2 | N | 10462606 | TRASTUZUMAB |
| 10005408 | 10003371 | 1.85 | null | Disease modification (D) | 2016-08-13 | 2016-08-13 | Bortezomib + MELPHALAN | N | N | 10462897 | SORAFENIB |
| 10005409 | 10003372 | null | null | Palliative (P) | 1983-07-01 | 2017-09-14 | VEPEMB | 02 | null | 10463743 | AML16 TRIAL |
| 10005410 | 10003373 | 1.69 | 54.1 | Palliative (P) | 2018-03-11 | 2018-03-17 | Methotrexate intrathecal | 2 | N | 10463889 | IBRUTINIB |
| 10005411 | 10003374 | 1.7 | 89.3 | null | 2016-01-05 | 2016-01-25 | CISPLATIN + FLUOROURACIL | N | N | 10464205 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN |
| 10005412 | 10003375 | null | 117 | Curative (C) | 2018-02-02 | 2018-02-03 | IPILIMUMAB + NIVOLUMAB | N | null | 10465238 | FLUOROURACIL + RT |
| 10005413 | 10003376 | 1.73 | 83.4 | Adjuvant (A) | 2017-12-07 | 2017-12-07 | CHLVPP | 2 | N | 10466177 | EVEROLIMUS |
| 10005414 | 10006860 | 1.63 | 0 | Curative (C) | 2015-05-10 | 2015-07-19 | IPILIMUMAB + NIVOLUMAB | 2 | N | 10466384 | CISPLATIN + FLUOROURACIL |
| 10005415 | 10003377 | null | 50.5 | Palliative (P) | 2018-05-04 | 2018-05-05 | Vemurafenib | N | null | 10466707 | IDELALISIB + RITUXIMAB |
| 10005416 | 10003378 | 1.6 | 0 | Curative (C) | 2018-02-22 | 2018-03-02 | Trastuzumab Subcutaneous | 2 | N | 10466925 | NEPTUNE TRIAL |
| 10005417 | 10003379 | 1.82 | 78.4 | Neo-adjuvant (N) | 2018-05-06 | 2018-05-15 | TEMOZOLOMIDE | N | N | 10469897 | OCTREOTIDE |
| 10005418 | 10003380 | 1.72 | 65 | Palliative (P) | 2018-05-28 | 2018-06-07 | CETUXIMAB | 02 | N | 10472095 | SUNITINIB |
| 10005419 | 10003381 | 1.65 | 83.5 | null | 2018-10-25 | 2018-11-10 | Lenalidomide 10mg (Cycle 1 to 25) | N | N | 10472261 | SUNITINIB |
| 10005420 | 10003382 | 1.59 | 0 | Curative (C) | 2018-07-27 | 2018-07-28 | TRASTUZUMAB | 2 | N | 10473371 | PAZOPANIB |
| 10005421 | 10003383 | 1.58 | null | Neo-adjuvant (N) | 2019-08-08 | 2019-08-29 | EC + DOCETAXEL | N | N | 10473528 | IPILIMUMAB + NIVOLUMAB |
| 10005422 | 10003384 | 1.69 | 67.5 | Palliative (P) | 2019-03-31 | 2019-04-11 | Pemetrexed | N | N | 10473566 | LENALIDOMIDE |
| 10005423 | 10003384 | 1.76 | 73 | Curative (C) | 2015-10-18 | 2015-10-26 | LENALIDOMIDE | N | N | 10473566 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN |
| 10005424 | 10003385 | 1.71 | 102 | Adjuvant (A) | 2019-07-05 | 2019-07-14 | STAMPEDE TRIAL | N | N | 10475222 | BORTEZOMIB + THALIDOMIDE |
| 10005425 | 10003386 | null | 60 | Disease modification (D) | 2017-09-13 | 2017-09-20 | Cyclophosphamide + Docetaxel | 2 | N | 10475259 | NOT MATCHED |
| 10005426 | 10003387 | 1.73 | 82.4 | Curative (C) | 2018-04-27 | 2018-05-07 | IPILIMUMAB + NIVOLUMAB | N | null | 10475395 | IRINOTECAN + MDG + PANITUMUMAB |
| 10005427 | 10003388 | 1.68 | 59.9 | null | 2019-04-18 | 2019-04-18 | Vemurafenib | N | N | 10476266 | BENDAMUSTINE |
| 10005428 | 10003389 | 1.88 | 82.4 | Neo-adjuvant (N) | 2018-10-29 | 2018-10-29 | CYCLOPHOSPHAMIDE + RITUXIMAB | 1 | N | 10476489 | CETUXIMAB + RT |
| 10005429 | 10003389 | 0 | 74 | Palliative (P) | 2018-12-30 | 2019-01-14 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 2 | Y | 10476489 | TEMOZOLOMIDE |
| 10005430 | 10003390 | 1.66 | 64.1 | Curative (C) | 2017-09-13 | 2017-09-28 | EP | N | N | 10477785 | IBRUTINIB |
| 10005431 | 10006863 | 1.73 | 93 | Palliative (P) | 2018-01-14 | 2018-01-21 | Cyclophosphamide High Dose | N | N | 10478486 | NOT MATCHED |
| 10005432 | 10006863 | null | 124.2 | Palliative (P) | 2015-10-13 | 2015-10-13 | AML18 PILOT TRIAL | 02 | N | 10478486 | DABRAFENIB + TRAMETINIB |
| 10005433 | 10003391 | 1.8 | 80 | Palliative (P) | 2018-07-13 | 2018-07-17 | BENDAMUSTINE + THALIDOMIDE | N | N | 10478977 | MPV |
| 10005434 | 10003392 | 1.67 | null | Palliative (P) | 2017-12-13 | 2017-12-13 | Cetuximab + Radiotherapy Load | N | N | 10479795 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 10005435 | 10003393 | 1.72 | null | Curative (C) | 2018-02-13 | 2018-02-14 | Pazopanib | N | N | 10481046 | CYTARABINE |
| 10005436 | 10003394 | 1.94 | 70 | Palliative (P) | null | 2016-08-16 | Capecitabine + Mitomycin | N | N | 10481969 | BEP |
| 10005437 | 10003394 | 1.6 | 88.3 | Palliative (P) | 2018-07-22 | 2018-08-28 | Mitomycin Intravesical | Y | N | 10481969 | CHLVPP |
| 10005438 | 10003395 | 1.76 | 83.2 | Curative (C) | 2018-11-14 | 2018-11-18 | DA-EPOCH-R | N | N | 10482233 | CETUXIMAB + IRINOTECAN + MDG |
| 10005439 | 10003395 | null | null | null | 2019-08-13 | 2019-08-25 | MELPHALAN + PREDNISOLONE | N | N | 10482233 | PAZOPANIB |
| 10005440 | 10003396 | 1.75 | 83 | Palliative (P) | 2018-02-02 | 2018-02-09 | Cisplatin +Fluorouracil (3 wk) | N | N | 10482674 | CISPLATIN + ETOPOSIDE + RT |
| 10005441 | 10003397 | 1.71 | 76 | Palliative (P) | 2015-05-21 | 2015-05-21 | DOXORUBICIN | 2 | N | 10482879 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 10005442 | 10003398 | 1.68 | 106 | Curative (C) | 2019-05-24 | 2019-05-28 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | 10483298 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 10005443 | 10003399 | 1.53 | 57.3 | Curative (C) | 2017-02-28 | 2017-03-03 | Gefitinib: 1 to 2 & 4 onwards | 2 | N | 10483915 | TEMOZOLOMIDE |
| 10005444 | 10003399 | 1.6 | 77.6 | Curative (C) | 2016-03-28 | 2016-04-02 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | N | 10483915 | TRASTUZUMAB |
| 10005445 | 10003400 | 1.78 | null | Adjuvant (A) | 2018-11-18 | 2018-11-27 | Cladribine (subcut) 5 days | 02 | N | 10484748 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 10005446 | 10003401 | 1.73 | 95.8 | Palliative (P) | 2019-06-28 | 2019-07-01 | Pazopanib | N | N | 10485611 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 10005447 | 10003402 | 1.77 | null | Curative (C) | 2018-11-08 | 2018-12-20 | Erlotinib | N | null | 10486400 | SUNITINIB |
| 10005448 | 10003403 | 1.65 | 96.4 | null | 2018-12-24 | 2019-01-21 | Vemurafenib | N | N | 10486974 | MPV |
| 10005449 | 10003403 | 1.7 | null | null | 2018-06-07 | 2018-07-11 | Capecitabine + Mitomycin | N | Y | 10486974 | RUXOLITINIB |
| 10005450 | 10003404 | 1.71 | 70 | Palliative (P) | 2018-11-08 | 2018-11-13 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | 10487678 | CISPLATIN + FLUOROURACIL |
| 10005451 | 10003405 | 1.72 | 68 | Palliative (P) | null | 2017-03-21 | Pazopanib | N | N | 10487777 | CETUXIMAB + IRINOTECAN + MDG |
| 10005452 | 10006868 | 1.63 | 75 | Disease modification (D) | 2015-09-30 | 2015-10-14 | RUXOLITINIB | 01 | Y | 10487888 | CLADRIBINE |
| 10005453 | 10003406 | 1.67 | 85.45 | Palliative (P) | 2019-06-03 | 2019-06-28 | CHLVPP | null | N | 10488657 | RCEOP |
| 10005454 | 10003407 | 1.75 | 108.6 | Curative (C) | 2016-11-18 | 2016-12-13 | PATHOS Trial | 02 | N | 10489253 | DOXORUBICIN EMBOLISATION |
| 10005455 | 10003408 | 1.74 | 66.8 | Palliative (P) | 2016-09-21 | 2016-09-21 | Erlotinib | 2 | N | 10489910 | FLAG + IDARUBICIN |
| 10005456 | 10003409 | 1.67 | 64.5 | Palliative (P) | 2018-06-18 | 2018-07-12 | EC + PACLITAXEL | N | N | 10490112 | CLADRIBINE |